lifestyle.capitolhilltimes.com

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis

Written by

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis – NEWSnet – News… as it used to be

More Press Releases

April 1, 2026

850 Autos Provides Expert Collision Repair for Vehicle Exterior

April 1, 2026

Protect Equipment Life with Professional Heating Service and Repair

April 1, 2026

LEIFRAS Co., Ltd. Signs Sponsorship Agreement with the Japan Sport Association (JSPO), Contributing to the Future of Sports

April 1, 2026

Elliott Management Statement on Mitsui O.S.K. Lines, Ltd.